Since first being proposed as a tandem gene family in 2001, the relatedness of the 5 SIBLING proteins (BSP, DMP1, DSPP, MEPE, and SPP1/OPN) has predominantly depended on arguments involving shared intron/exon properties as well as conserved protein biochemical properties (e.g. unstructured and acidic) and specific peptide motifs (e.g. phosphorylation and integrin-binding RGD). This report discusses the evidence that an ancient DMP1 gene underwent a simple duplication in the common ancestor of mammals and reptiles and then separately evolved into DSPP-like paralogs in the 2 classes. Genomic sequence analyses show that different copies of the original DMP1 duplication process were selected by mammalian and reptilian (anole lizard) classes to acquire genetically different but biochemically similar phosphoserine-rich repeat domains by convergent evolution. Mammals, for example, expanded phosphoserine motifs encoded exclusively using motifs containing AGC/T serine codons while the reptile line’s repeats also used TCN-encoding serine codons. A similar analysis of the origins of the other 4 SIBLINGs will require even more detailed analysis as genome sequences of various fish and amphibia become available.

Keywords:
DSPP, DMP1, SIBLINGs
1.
Aplin, H.M., K.L. Hirst, M.J. Dixon (1999) Refinement of the dentinogenesis imperfecta type II locus to an interval of less than 2 centiMorgans at chromosome 4q21 and the creation of a yeast artificial chromosome contig of the critical region. J Dent Res 78: 1270–1276.
2.
Bellahcène, A., V. Castronovo, K.U. Ogbureke, L.W. Fisher, N.S. Fedarko (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8: 212–226.
3.
Crosby, A.H., M.S. Lyu, K. Lin, O.W. McBride, O.W. Kerr, H.M. Aplin, L.W. Fisher, M.F. Young, C.A. Kozak, M.J. Dixon (1996) Mapping of the human and mouse bone sialoprotein and osteopontin loci. Mamm Genome 7: 149–151.
4.
Feng, J.Q., X. Luan, J. Wallace, D. Jing, T. Ohshima, A.B. Kulkarni, R.N. D’Souza, C.A. Kozak, l.M. MacDougal (1998) Genomic organization, chromosomal mapping, and promoter analysis of the mouse dentin sialophosphoprotein (Dspp) gene, which codes for both dentin sialoprotein and dentin phosphoprotein. J Biol Chem 273: 9457–9464.
5.
Fisher, L.W., N.S. Fedarko (2003) Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44: 33–40.
6.
Fisher, L.W., J.D. Termine, M.F. Young (1989) Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264: 4571–4576.
7.
Fisher, L.W., D.A. Torchia, B. Fohr, M.F. Young, N.S. Fedarko (2001) Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 280: 460–465.
8.
Kawasaki, K. (2009) The SCPP gene repertoire in bony vertebrates and graded differences in mineralized tissues. Dev Genes Evol 219: 147–157.
9.
Kawasaki, K., K.M. Weiss (2008) SCPP gene evolution and the dental mineralization continuum. J Dent Res 87: 520–531.
10.
McKnight, D.A., L.W. Fisher (2009) Molecular evolution of dentin phosphoprotein among toothed and toothless animals. BMC Evol Biol 9: 299.
11.
Price, P.A., M.K. Williamson (1985) Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J Biol Chem 260: 14971–14975.
12.
Sire, J.Y., S.C. Delgado, M. Girondot (2008) Hen’s teeth with enamel cap: from dream to impossibility. BMC Evol Biol 8: 246.
13.
von Marschall, Z., L.W. Fisher (2010) Dentin sialophosphoprotein (DSPP) is cleaved into its two natural dentin matrix products by three isoforms of bone morphogenetic protein-1 (BMP1). Matrix Biol 29: 295–303.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.